Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-016089

EVP, Chief Financial Officer sold 363 shares at $16.88 ($6,129)

  • EVP, Chief Financial Officer acquired 1,049 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McClellan Michael James · EVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-03 Exercise or conversion : show line 1 in the form +1,049 12,693.27 D
2019-03-04 Sale : show line 2 in the form −363 $16.88 $6,129 12,330.27 D
Open-market sales · 363 sh · avg $16.88 · $6,129

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-03 Exercise or conversion : show line 3 in the form Restricted Share Units −1,049 2,099 D
Loading xslF345X03/doc4.xml…